Cripto/GRP78 Modulation of the TGF-β Pathway in Development and Oncogenesis

Overview

Journal FEBS Lett

Specialty Biochemistry

Date 2012 Feb 7

PMID 22306319

Citations 42

Authors

Peter C Gray

Wylie Vale

Affiliations

Soon will be listed here.

Abstract

Cripto is a small, GPI-anchored signaling protein that regulates cellular survival, proliferation, differentiation and migration during normal developmental processes and tumorigenesis. Cripto functions as an obligatory co-receptor for the TGF-β ligands Nodal, GDF1 and GDF3 but attenuates signaling of others such as activin-A, activin-B and TGF-β1. Soluble, secreted forms of Cripto also activate Src, ras/raf/MAPK and PI3K/Akt pathways via a mechanism that remains largely obscure. This review describes the biological roles and signaling mechanisms of Cripto, highlighting our identification of the 78 kDa glucose regulated protein (GRP78) as a cell surface receptor/co-factor required for Cripto signaling via both TGF-β and Src/MAPK/PI3K pathways. We discuss emerging evidence indicating that Cripto/GRP78 signaling regulates normal somatic stem cells and their tumorigenic counterparts.

Citing Articles

GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells.

Lin M, Mo Y, Li C, Liu Y, Feng X Med Oncol. 2025; 42(2):49.

PMID: 39827214 DOI: 10.1007/s12032-024-02586-0.

CRIPTO's multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient data.

Rodrigues Sousa E, de Brot S, Zoni E, Zeinali S, Brunello A, Scarpa M Oncogene. 2024; 44(7):462-475.

PMID: 39592836 PMC: 11810784. DOI: 10.1038/s41388-024-03230-x.

Human Cripto-1 and Cripto-3 Protein Expression in Normal and Malignant Settings That Conflicts with Established Conventions.

Cuttitta F, Garcia-Sanmartin J, Feng Y, Sunday M, Kim Y, Martinez A Cancers (Basel). 2024; 16(21).

PMID: 39518018 PMC: 11545644. DOI: 10.3390/cancers16213577.

Inhibin subunit beta B (INHBB): an emerging role in tumor progression.

Liu Y, Zhou Q, Zou G, Zhang W J Physiol Biochem. 2024; 80(4):775-793.

PMID: 39183219 DOI: 10.1007/s13105-024-01041-y.

An Exploratory Data Analysis from Ovine and Bovine RNA-Seq Identifies Pathways and Key Genes Related to Cervical Dilatation.

Goncalves J, Ferraz J, Meirelles F, Nociti R, Oliveira M Animals (Basel). 2023; 13(13).

PMID: 37443850 PMC: 10339884. DOI: 10.3390/ani13132052.

References

Tao Q, Yokota C, Puck H, Kofron M, Birsoy B, Yan D . Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos. Cell. 2005; 120(6):857-71. DOI: 10.1016/j.cell.2005.01.013. View

Chu J, Shen M . Functional redundancy of EGF-CFC genes in epiblast and extraembryonic patterning during early mouse embryogenesis. Dev Biol. 2010; 342(1):63-73. PMC: 2866749. DOI: 10.1016/j.ydbio.2010.03.009. View

Lee C, Jan H, Lai J, Ma H, Hueng D, Lee Y . Nodal promotes growth and invasion in human gliomas. Oncogene. 2010; 29(21):3110-23. DOI: 10.1038/onc.2010.55. View

Gonzalez-Gronow M, Selim M, Papalas J, Pizzo S . GRP78: a multifunctional receptor on the cell surface. Antioxid Redox Signal. 2009; 11(9):2299-306. DOI: 10.1089/ARS.2009.2568. View

Akhurst R, Derynck R . TGF-beta signaling in cancer--a double-edged sword. Trends Cell Biol. 2001; 11(11):S44-51. DOI: 10.1016/s0962-8924(01)02130-4. View

Kelber J, Panopoulos A, Shani G, Booker E, Belmonte J, Vale W . Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 2009; 28(24):2324-36. PMC: 2749668. DOI: 10.1038/onc.2009.97. View

Misra U, Deedwania R, Pizzo S . Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J Biol Chem. 2006; 281(19):13694-13707. DOI: 10.1074/jbc.M511694200. View

Brown S, Teo A, Pauklin S, Hannan N, Cho C, Lim B . Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells. 2011; 29(8):1176-85. DOI: 10.1002/stem.666. View

Adkins H, Bianco C, Schiffer S, Rayhorn P, Zafari M, Cheung A . Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest. 2003; 112(4):575-87. PMC: 171388. DOI: 10.1172/JCI17788. View

10.

Gray P, Shani G, Aung K, Kelber J, Vale W . Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol. 2006; 26(24):9268-78. PMC: 1698529. DOI: 10.1128/MCB.01168-06. View

11.

Postovit L, Margaryan N, Seftor E, Kirschmann D, Lipavsky A, Wheaton W . Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A. 2008; 105(11):4329-34. PMC: 2393795. DOI: 10.1073/pnas.0800467105. View

12.

Massague J, Gomis R . The logic of TGFbeta signaling. FEBS Lett. 2006; 580(12):2811-20. DOI: 10.1016/j.febslet.2006.04.033. View

13.

Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H . Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Hum Gene Ther. 2004; 15(6):553-61. DOI: 10.1089/104303404323142006. View

14.

Lawrence M, Margaryan N, Loessner D, Collins A, Kerr K, Turner M . Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate. 2011; 71(11):1198-209. PMC: 3234312. DOI: 10.1002/pros.21335. View

15.

Constam D . Riding shotgun: a dual role for the epidermal growth factor-Cripto/FRL-1/Cryptic protein Cripto in Nodal trafficking. Traffic. 2009; 10(7):783-91. DOI: 10.1111/j.1600-0854.2009.00874.x. View

16.

Bianco C, Normanno N, De Luca A, Maiello M, Wechselberger C, Sun Y . Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein. J Cell Physiol. 2002; 190(1):74-82. DOI: 10.1002/jcp.10037. View

17.

Fu Y, Wey S, Wang M, Ye R, Liao C, Roy-Burman P . Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci U S A. 2008; 105(49):19444-9. PMC: 2614780. DOI: 10.1073/pnas.0807691105. View

18.

Liu Y, Steiniger S, Kim Y, Kaufmann G, Felding-Habermann B, Janda K . Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery. Mol Pharm. 2007; 4(3):435-47. PMC: 2533281. DOI: 10.1021/mp060122j. View

19.

Wu M, Jan C, Tsay Y, Yu Y, Huang C, Lin S . Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer. 2010; 9:283. PMC: 2987982. DOI: 10.1186/1476-4598-9-283. View

20.

Xu C, Liguori G, Persico M, Adamson E . Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development. 1999; 126(3):483-94. DOI: 10.1242/dev.126.3.483. View